Our Services
Medical Information
Helpful Resources
Published on: 10/27/2026
Regular Pepto-Bismol is not recommended for children under 12 because its active ingredient, bismuth subsalicylate, is a salicylate related to aspirin and carries a risk of Reye's syndrome, a rare but serious condition affecting the liver and brain in children and teens recovering from viral illnesses like flu or chickenpox. Children's Pepto is a different product that uses calcium carbonate instead and is labeled for ages 2 and up, so the two should never be used interchangeably. There are also important considerations around dosing, hidden salicylate exposure from other medicines, black stool or tongue discoloration, and when stomach symptoms in a child signal something more urgent, all of which are explained below.
Because abdominal pain, nausea, and diarrhea in both children and adults can stem from many different causes, guessing at an over-the-counter fix can delay the right care. Take a free, instant, online symptom check to better understand what may be driving your symptoms and what sensible next steps look like.
Last reviewed for medical accuracy: 10/27/2026
Many parents wonder about the Pepto Bismol age limit for kids, especially when a child has diarrhea, nausea, heartburn, or an upset stomach. In the United States, regular Pepto-Bismol products containing bismuth subsalicylate are generally labeled for adults and children 12 years and older. Children under 12 should not be given regular Pepto-Bismol unless a doctor specifically recommends it.
The restriction is not simply because children are smaller or more sensitive to medicine. Regular Pepto-Bismol contains a form of salicylate, the same broad medicine family that includes aspirin. Salicylates can cause serious problems in children and teenagers who have, or are recovering from, certain viral infections.
The main concern is a rare but potentially life-threatening illness called Reye’s syndrome. Reye’s syndrome can cause swelling of the brain and serious liver problems. It has been associated with giving aspirin or other salicylate-containing medicines to children and teenagers during or shortly after viral infections such as influenza or chickenpox.
Bismuth subsalicylate is not identical to aspirin, but it does contain a salicylate component. Because it is difficult for a parent to know whether a child’s stomach symptoms are related to a viral illness, product labels take a cautious approach.
This is why U.S. labeling for regular Pepto-Bismol generally says:
Reye’s syndrome is rare, and avoiding regular Pepto-Bismol does not mean that most children with diarrhea or vomiting are in danger. The age restriction is a safety precaution designed to prevent an avoidable risk.
The active ingredient in standard Pepto-Bismol is bismuth subsalicylate. It may help relieve several digestive symptoms, including:
The “subsalicylate” part is important. Although bismuth products may sound similar, not all products contain the same ingredients. A product marketed for children may contain a different active ingredient, such as calcium carbonate, or may have different age directions.
Do not assume that a product is safe for a young child simply because the word “Pepto” appears on the package. Read the Drug Facts label carefully, check the active ingredients, and follow the age instructions for that exact product.
If you are unsure, ask a pharmacist or speak to a doctor before giving any over-the-counter stomach medicine to a child.
For many healthy children age 12 and older, regular Pepto-Bismol may be used according to the package directions. However, age alone does not make it appropriate for everyone.
A teenager should check with a healthcare professional before using bismuth subsalicylate if they:
Never give more than the recommended dose. Using several products with similar ingredients can accidentally lead to an excessive salicylate dose.
For most children with mild diarrhea or vomiting, the first priority is preventing dehydration rather than stopping every symptom. Offer frequent, small amounts of fluid. An oral rehydration solution is often more suitable than plain water alone because it replaces both fluids and important salts.
Helpful steps may include:
Some children’s stomach products are specifically labeled for younger ages, but they are not automatically interchangeable with regular Pepto-Bismol. Check the active ingredient, minimum age, dosing instructions, and warnings. A pharmacist can help you select an appropriate option based on the child’s age and symptoms.
Bismuth can temporarily turn the tongue dark or make stools look grayish-black. This is a known effect and is usually harmless. The color typically returns to normal after the medicine is stopped.
However, black, tarry stools can also be a sign of bleeding in the digestive tract. If the stool is sticky or tar-like, has a strong unusual odor, or appears along with weakness, dizziness, vomiting blood, or severe stomach pain, do not assume it is only from Pepto-Bismol. Speak to a doctor promptly.
Diarrhea and vomiting are often caused by short-lived infections, but young children can become dehydrated more quickly than adults. Contact a healthcare professional if a child has:
Seek urgent medical help for difficulty breathing, confusion, collapse, a seizure, severe dehydration, or a child who is difficult to wake. If anything could be life-threatening or serious, speak to a doctor or seek emergency care immediately rather than trying to manage it with an over-the-counter medicine.
For general guidance about symptoms, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It cannot diagnose a child or replace professional care, but it may help you organize symptoms and decide what level of medical attention may be appropriate.
The usual Pepto Bismol age limit for kids is 12 years and older for regular products containing bismuth subsalicylate. Children under 12 should not receive regular Pepto-Bismol unless a doctor tells you to use it. The reason is that bismuth subsalicylate contains a salicylate, which may increase the risk of Reye’s syndrome when used during or after certain viral infections.
Always check the exact product label, avoid combining medicines with similar ingredients, and focus on hydration when a child has vomiting or diarrhea. When symptoms are severe, unusual, persistent, or potentially serious, speak to a doctor.
(References)
* Szap MD. Hidden salicylates. Am J Dis Child. 1989 Feb;143(2):142. doi: 10.1001/archpedi.1989.02150140024013. PMID: 2916482.
* Gordon MF, Abrams RI, Rubin DB, Barr WB, Correa DD. Bismuth toxicity. Neurology. 1994 Dec;44(12):2418. doi: 10.1212/wnl.44.12.2418-a. PMID: 7991149.
* Gao X, Zhang X, Wang Y, Fan C. Effects of morphology and surface hydroxyl on the toxicity of BiOCl in human HaCaT cells. Chemosphere. 2016 Nov;163:438-445. doi: 10.1016/j.chemosphere.2016.08.063. Epub 2016 Aug 24. PMID: 27565311.
* Badrigilan S, Choupani J, Khanbabaei H, Hoseini-Ghahfarokhi M, Webster TJ, Tayebi L. Bismuth-Based Nanomaterials: Recent Advances in Tumor Targeting and Synergistic Cancer Therapy Techniques. Adv Healthc Mater. 2020 Apr;9(7):e1901695. doi: 10.1002/adhm.201901695. Epub 2020 Mar 6. PMID: 32142225.
* Badrigilan S, Heydarpanahi F, Choupani J, Jaymand M, Samadian H, Hoseini-Ghahfarokhi M, Webster TJ, Tayebi L. A Review on the Biodistribution, Pharmacokinetics and Toxicity of Bismuth-Based Nanomaterials. Int J Nanomedicine. 2020;15:7079-7096. doi: 10.2147/IJN.S250001. Epub 2020 Sep 25. PMID: 33061369; PMCID: PMC7526011.
* Chan PF, Ang KP, Hamid RA. A bismuth diethyldithiocarbamate compound induced apoptosis via mitochondria-dependent pathway and suppressed invasion in MCF-7 breast cancer cells. Biometals. 2021 Apr;34(2):365-391. doi: 10.1007/s10534-021-00286-0. Epub 2021 Feb 8. PMID: 33555494.
* Zhao P, Li B, Li Y, Chen L, Wang H, Ye L. DNA-Templated ultrasmall bismuth sulfide nanoparticles for photoacoustic imaging of myocardial infarction. J Colloid Interface Sci. 2022 Jun;615:475-484. doi: 10.1016/j.jcis.2022.01.194. Epub 2022 Feb 5. PMID: 35150955.
* Zhang Q, Liu Y, Wang Z, Wang P, Zheng Z, Cheng H, Qin X, Zhang X, Dai Y, Huang B. A biocompatible bismuth based metal-organic framework as efficient light-sensitive drug carrier. J Colloid Interface Sci. 2022 Jul;617:578-584. doi: 10.1016/j.jcis.2022.01.188. Epub 2022 Mar 9. PMID: 35303641.
* Zelepukin IV, Ivanov IN, Mirkasymov AB, Shevchenko KG, Popov AA, Prasad PN, Kabashin AV, Deyev SM. Polymer-coated BiOCl nanosheets for safe and regioselective gastrointestinal X-ray imaging. J Control Release. 2022 Sep;349:475-485. doi: 10.1016/j.jconrel.2022.07.007. Epub 2022 Jul 18. PMID: 35839934.
* Wang J, Fu D, Tang C, Shu G, Zhang X, Zhang X, Pan J, Sun SK. Bismuth Chelate-Mediated Digital Subtraction Angiography. Adv Healthc Mater. 2024 Nov;13(28):e2401653. doi: 10.1002/adhm.202401653. Epub 2024 Jun 16. PMID: 38830126.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.